BIO vs KFS · rev $651.0M vs rev $109.4M
BIO (BIO) versus Kingsway Financial Services Inc (KFS) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Kingsway Financial Services Inc (KFS) is a asset management company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported KFS revenue for 2024-12-31 was $109.4M. Net income was -$8.3M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. KFS currently screens at market cap $307.2M.
BIO currently screens at market cap $0. KFS currently screens at market cap $307.2M.
Not investment advice. Open the BIO and KFS stock pages for the full models.
Not investment advice.